| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Revolution Medicines, Inc. | $147.21 | -0.5% | $29B | -24.7 | -66.2% | — | Healthcare | 269.9% | — | ||
| 2 | Incyte Corporation | $97.47 | 0.3% | $19.47B | 15.2 | 2112.5% | — | Healthcare | 56.9% | 21.5% | ||
| 3 | Genmab A/S | $27.54 | 1.8% | $16.96B | 14.5 | 45.9% | — | Healthcare | 27.8% | 21% | ||
| 4 | Exelixis, Inc. | $44.42 | 0.6% | $11.28B | 16.0 | 37.9% | — | Healthcare | 11.5% | 3.3% | ||
| 5 | ImmunityBio, Inc. | $7.58 | 2% | $7.47B | -12.2 | 55.3% | — | Healthcare | 261% | 1026% | ||
| 6 | Merus N.V. | $90.00 | 0% | $6.83B | -26.9 | -36.9% | — | Healthcare | 107.6% | 55.9% | ||
| 7 | Nuvalent, Inc. | $101.47 | -1.1% | $6.74B | -25.8 | -53.3% | — | Healthcare | 34.5% | — | ||
| 8 | ASCENTAGE PHARMA GROUP INTERNATIONAL | $21.90 | -0.5% | $6.62B | -111.6 | 84.4% | — | Healthcare | -13.4% | 264.8% | ||
| 9 | Celcuity Inc. | $141.69 | -2.3% | $6.13B | -50.1 | -40.6% | — | Healthcare | 1205.9% | — | ||
| 10 | CG Oncology, Inc. Common stock | $67.18 | -0.8% | $5.67B | -32.3 | -61.2% | — | Healthcare | 138.4% | 254.7% | ||
| 11 | Tango Therapeutics, Inc. | $24.20 | 6.6% | $3.29B | -27.8 | 27.5% | — | Healthcare | 1604.2% | 48.3% | ||
| 12 | Erasca, Inc. | $9.99 | -1.5% | $2.83B | -14.5 | 45.8% | — | Healthcare | 589% | — | ||
| 13 | Arcus Biosciences, Inc. | $26.06 | 0% | $2.62B | -7.9 | 24.6% | — | Healthcare | 191.5% | 67.4% | ||
| 14 | IDEAYA Biosciences, Inc. | $28.80 | -0.3% | $2.53B | -22.5 | 60.3% | — | Healthcare | 40.7% | 3024.4% | ||
| 15 | Enliven Therapeutics, Inc. | $41.58 | -0.1% | $2.47B | -22.7 | 3.2% | — | Healthcare | 103.9% | — | ||
| 16 | Relay Therapeutics, Inc. | $13.00 | -0.8% | $2.46B | -8.1 | 29.6% | — | Healthcare | 291.6% | 39% | ||
| 17 | Day One Biopharmaceuticals, Inc. | $21.53 | 0% | $2.22B | -20.7 | 4.6% | — | Healthcare | 187.8% | 20.6% | ||
| 18 | Zymeworks Inc. | $26.68 | -0.4% | $1.98B | -24.7 | 32.9% | — | Healthcare | 107.6% | 38.9% | ||
| 19 | Inhibrx Biosciences, Inc. | $128.12 | 0.1% | $1.87B | -14.2 | -107.7% | — | Healthcare | 939.1% | 550% | ||
| 20 | Tyra Biosciences, Inc. | $33.93 | -3.4% | $1.82B | -16.9 | -33.1% | — | Healthcare | 223.1% | — | ||
| 21 | Syndax Pharmaceuticals, Inc. | $20.10 | 0.7% | $1.77B | -6.1 | 40.3% | — | Healthcare | 48.1% | 396.7% | ||
| 22 | Nuvation Bio Inc. | $4.83 | 9.5% | $1.67B | -8.1 | 81.7% | — | Healthcare | 102.9% | 1205.5% | ||
| 23 | Immunocore Holdings plc | $28.84 | 1.1% | $1.46B | -54.4 | 47.3% | — | Healthcare | -5.8% | 20.2% | ||
| 24 | Monte Rosa Therapeutics, Inc. | $19.35 | -1.1% | $1.27B | -42.1 | 40.8% | — | Healthcare | 317.9% | 63.5% | ||
| 25 | ArriVent BioPharma, Inc. Common Stock | $29.83 | -1.8% | $1.27B | -6.9 | -80.8% | — | Healthcare | 43.3% | — | ||
| 26 | Bicara Therapeutics Inc. Common Stock | $23.16 | 1.9% | $1.26B | -18.5 | -104.6% | — | Healthcare | 65.4% | — | ||
| 27 | Olema Pharmaceuticals, Inc. | $14.64 | 0.1% | $1.19B | -7.8 | 17.6% | — | Healthcare | 163.3% | — | ||
| 28 | Corvus Pharmaceuticals, Inc. | $15.70 | -2% | $1.17B | -29.6 | 45.4% | — | Healthcare | 339.8% | — | ||
| 29 | UroGen Pharma Ltd. | $23.83 | 2.3% | $1.15B | -7.5 | 0.9% | — | Healthcare | 117.6% | 21.4% | ||
| 30 | Geron Corporation | $1.65 | 5.1% | $1B | -6.1 | 62.3% | — | Healthcare | 16.2% | 522.1% | ||
| 31 | ORIC Pharmaceuticals, Inc. | $9.57 | -0.6% | $960M | -6.5 | 23% | — | Healthcare | 67.9% | — | ||
| 32 | Janux Therapeutics, Inc. | $14.33 | -0.6% | $865M | -7.8 | -43% | — | Healthcare | -51.9% | 68.9% | ||
| 33 | Kura Oncology, Inc. | $9.29 | 0.4% | $816M | -2.9 | -56.7% | — | Healthcare | 38.2% | 25.2% | ||
| 34 | Xilio Therapeutics, Inc. | $7.71 | -9.7% | $644M | -1.8 | 78% | — | Healthcare | -25.6% | 589.9% | ||
| 35 | SELLAS Life Sciences Group, Inc. | $4.87 | -3% | $609M | -19.5 | 58.6% | — | Healthcare | 184.8% | — | ||
| 36 | Aura Biosciences, Inc. | $8.90 | 6.6% | $561M | -5.1 | -12.1% | — | Healthcare | 50.3% | — | ||
| 37 | Crescent Biopharma, Inc. | $18.08 | 0.9% | $498M | -1.4 | -442.8% | — | Healthcare | -34.2% | — | ||
| 38 | ADC Therapeutics S.A. | $3.76 | 2.2% | $478M | -3.4 | 27.4% | — | Healthcare | 164.8% | 4.4% | ||
| 39 | Adlai Nortye Ltd. | $14.93 | -0.3% | $466M | -3.1 | 51% | — | Healthcare | 635.5% | — | ||
| 40 | NovaBridge Biosciences | $2.38 | -0.8% | $446M | -3.6 | 89.4% | — | Healthcare | 178.4% | -100% | ||